SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019299
Filing Date
2022-05-10
Accepted
2022-05-10 16:26:44
Documents
81
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sana-10q_20220331.htm   iXBRL 10-Q 3137686
2 EX-31.1 sana-ex311_6.htm EX-31.1 21306
3 EX-31.2 sana-ex312_7.htm EX-31.2 19851
4 EX-32.1 sana-ex321_8.htm EX-32.1 9773
5 EX-32.2 sana-ex322_11.htm EX-32.2 9487
6 GRAPHIC g3lydw5yfbhr000001.jpg GRAPHIC 192599
  Complete submission text file 0001564590-22-019299.txt   11202522

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA sana-20220331.xsd EX-101.SCH 59219
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sana-20220331_cal.xml EX-101.CAL 48436
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sana-20220331_def.xml EX-101.DEF 209129
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sana-20220331_lab.xml EX-101.LAB 450199
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sana-20220331_pre.xml EX-101.PRE 378765
75 EXTRACTED XBRL INSTANCE DOCUMENT sana-10q_20220331_htm.xml XML 2232475
Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39941 | Film No.: 22910121
SIC: 2836 Biological Products, (No Diagnostic Substances)